Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected PatientsXiaoqin Le, Yinzhong Shen, Zhenyan Wang et al.|Viruses|2024Cited by 8
Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional studyYueming Shao, Jun Chen, Tangkai Qi et al.|Archives of Osteoporosis|2024Cited by 7
Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical TrialYueming Shao, Jun Chen, Tangkai Qi et al.|Infectious Diseases and Therapy|2025Cited by 2
Double-Dose Dolutegravir and Lamivudine Versus Efavirenz-Based Antiretroviral Therapy for Patients Coinfected with HIV and Tuberculosis: A Multicentre Open-Label, Randomised TrialXiaoqin Le, Yinzhong Shen, Tangkai Qi et al.|EMJ Microbiology & Infectious Diseases|2025Cited by 0